|Articles|April 12, 2016
OmniComm Penetrates Growing Israeli Life Sciences Market
OmniComm has announced the signing of an agreement with Medistat Ltd.
Advertisement
OmniComm has announced the signing of an agreement with Medistat Ltd., headquartered in Tel Aviv, Israel; to address the clinical trial needs of the growing Israeli life sciences sector. Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- How the NIMBLE Study Supported Adherence With Quarterly Dosing of Cemdisiran
September 18th 2025
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
2
Everything to Know About FDA’s Push Towards Radical Transparency in 2025
3
Enhancing Clinical Trial Data Accuracy Through the IQVIA and Veeva Partnership
4
Phase IV Trial Shows Strong Immune Response from Moderna’s Updated Spikevax Against LP.8.1 Variant of COVID-19
5